By Mill Chart
Last update: Jan 25, 2024
Discover BRISTOL-MYERS SQUIBB CO (NYSE:BMY)—a stock that our stock screener has recognized as a solid dividend pick with strong fundamentals. NYSE:BMY showcases decent financial health and profitability while providing a sustainable dividend. We'll explore the specifics further.
ChartMill assigns a Dividend Rating to each stock, ranging from 0 to 10. This rating is calculated by analyzing various dividend elements, such as yield, historical performance, dividend growth, and sustainability. NYSE:BMY has been awarded a 7 for its dividend quality:
To gauge a stock's financial health, ChartMill utilizes a Health Rating on a scale of 0 to 10. This comprehensive evaluation encompasses liquidity and solvency, both in absolute terms and in comparison to industry peers. NYSE:BMY has earned a 5 out of 10:
ChartMill's Profitability Rating offers a unique perspective on stock analysis, providing scores from 0 to 10. These ratings consider a wide range of profitability metrics and margins, both in comparison to industry peers and on their own merits. For NYSE:BMY, the assigned 8 is a significant indicator of profitability:
More Best Dividend stocks can be found in our Best Dividend screener.
Our latest full fundamental report of BMY contains the most current fundamental analsysis.
This article should in no way be interpreted as advice in any way. The article is based on the observed metrics at the time of writing, but you should always make your own analysis and trade or invest at your own responsibility.
BRISTOL-MYERS SQUIBB CO
NYSE:BMY (4/19/2024, 7:04:00 PM)
After market: 48.93 0 (0%)48.93
+0.63 (+1.3%)
These stocks pay between 3.2% and 6.7% in dividends.
These stocks pay between 3.2% and 6.7% in dividends.
Small-cap stocks have been the market laggards but these standouts showed how to beat even top-tier tech names at their own game.
Make the most of a modest investment by putting it into Intuitive Surgical, Bristol Myers Squibb, and Novo Nordisk.
Make the most of a modest investment by putting it into Intuitive Surgical, Bristol Myers Squibb, and Novo Nordisk.
If you want to outperform the S&P 500, consider these undervalued dividend stocks for juicy yields and high total return potential.
These income stocks look like good options at current levels.
The economy, and pharma industry, are projected to grow massively. You should invest in these top three pharma stocks.
InvestorPlace - Stock Market News, Stock Advice & Trading Tips The future of the U.S. economy appears promising, with robust growth and strong...
The company was testing a potential treatment for schizophrenia in rabbits, but found a notable side effect.
Bristol Myers Squibb stock sports an attractive valuation and dividend yield. Is it a more compelling buy than the Vanguard S&P 500 ETF?